Tissue Specific Pathways for Estrogen Regulation of Ovarian Cancer Growth and Metastasis

Menopausal estrogen (E2) replacement therapy increases the risk of estrogen receptor (ER)-positive epithelial ovarian cancers (EOC). Whether E2 is tumorigenic or promotes expansion of undiagnosed pre-existing disease is unknown. To determine E2 effects on tumor promotion, we developed an intraperito...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Spillman, Monique A., Manning, Nicole G., Dye, Wendy W., Sartorius, Carol A., Post, Miriam D., Harrell, J. Chuck, Jacobsen, Britta M., Horwitz, Kathryn B.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2010
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3804411/
https://ncbi.nlm.nih.gov/pubmed/20959477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-10-1238
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia